Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine

Test for p53 Needed to Prescreen Blood Cancer Patients

Caption: Death of tumor cells after treatment with protease inhibitors (green). Left, tumor lacking p53, with only fraction of cells killed. Right, tumor producing p53, with massive cell death.

Credit: Andrei Thomas-Tikhonenko, PhD, University of Pennsylvania; Blood

Usage Restrictions: None

Related news release: Study suggests test for p53 is needed to prescreen patients for blood cancer drugs